The Otto Aufranc award: Bone augmentation around and within porous implants by local bisphosphonate elution

Clinical Orthopaedics and Related Research

Volumn 441, Issue , 2005, Pages 30-39

  Tanzer, Michael ^a   Karabasz, Dorota ^c   Krygier, Jan J ^c   Cohen, Robert ^c   Bobyn, J Dennis ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; TANTALUM; ZOLEDRONIC ACID; BIOMATERIAL; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE MATRIX; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; IMAGE ANALYSIS; IMPLANT; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROSTHESIS; ULNA; ANIMAL; ARTICLE; BONE REGENERATION; DRUG EFFECT; PROSTHESES AND ORTHOSES; RADIOGRAPHY; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DIPHOSPHONATES; DOGS; DRUG DELIVERY SYSTEMS; DURAPATITE; IMIDAZOLES; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; OSSEOINTEGRATION; PROSTHESES AND IMPLANTS; TANTALUM; ULNA;

EID: 33644804195     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000194728.62996.2d     Document Type: Conference Paper

References (54)

1. Alberts LR: Effects of periosteal activation agent on bone repair and ingrowth. J Biomed Mater Res 21:429-442, 1987.
2. Åstrand J, Aspenberg P: Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening. J Orthop Res 22:244-249, 2004.
3. Barrack RL, Cook SD, Salkeld SL, et al: Induction of bone ingrowth from an acetabular defect to a porous surface with osteogenic protein-1. Clin Orthop Relat Res 417:41-49, 2003.
4. Bauer TW, Geesink RC, Zimmerman R, McMahon JT: Hydroxyapatite-coated femoral stems: Histological analysis of components retrieved at autopsy. J Bone Joint Surg 73A:1439-1452, 1991.
5. Berry JL, Geiger JM, Moran JM, Skraba JS, Greenwald AS: Use of tricalcium phosphate or electrical stimulation to enhance the bone-porous implant interface. J Biomed Mater Res 20:65-77, 1986.
6. Binderman I, Adut M, Yaffe A: Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 71:1236-1240, 2000.
7. Bobyn JD, Jacobs JJ, Tanzer M, et al: The susceptibility of smooth implant surfaces to peri-implant fibrosis and migration of polyethylene wear debris. Clin Orthop Relat Res 311:21-39, 1995.
8. Bobyn JD: Stackpool GJ, Hacking SA, Tanzer M, Krygier JJ: Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg 81B:907-914, 1999.
9. Bobyn JD, Toh K-K, Hacking SA, Tanzer M, Krygier JJ: The tissue response to porous tantalum acetabular cups: A canine model. J Arthroplasty 14:347-354, 1999.
10. Bobyn JD, Tanzer M, Harvey EJ, Krygier JJ, Little DG: Zoledronic acid causes enhancement of net bone growth into porous implants. J Bone Joint Surg 87B:416-420, 2005.
11. Bragdon CR, Doherty AM, Rubash HE, et al: Efficacy of MBP-2 to induce bone ingrowth in gap and non-gap regions of a THR model. Clin Orthop Relat Res 417:50-61, 2003.
12. Cole BJ, Bostrom MPG, Pritchard TL, et al: Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res 345:219-228, 1997.
13. Cook SD, Thomas KA, Kay JF, Jarcho M: Hydroxyapatite-coated porous titanium for use as an orthopedic biologic attachment system. Clin Orthop Relat Res 230:303-312, 1988.
14. Cook SD, Salkeld SL, Patron LP, Barrack RL: The effect of demineralized bone matrix gel on bone ingrowth and fixation of porous implants. J Arthroplasty 17:402-408, 2002.
15. D'Antonio JA, Capello WN, Manley MT, Geesink R: Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year followup. Clin Orthop Relat Res 393:101-111, 2001.
16. D'Antonio JA, Capello WN, Manley MT, Geesink R: Hydroxyapatite femoral stems for total hip arthroplasty: 10-year to 13-year followup. Clin Orthop Relat Res 393:101-111, 2001.
17. Day JS, Ding M, Bednarz P, et al: Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22:465-471, 2004.
18. Derntl M, Syeda B, Beran G, et al: Prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents. J Interv Cardiol 15:477-483, 2002.
19. Engh CA, Claus AM, Hopper RH, Engh CA: Long-term results using the anatomic medullary locking prosthesis. Clin Orthop Relat Res 393:137-146, 2001.
20. Geesink R: Hydroxyapatite-coated total hip prostheses. Clin Orthop Relat Res 225:147-170, 1990.
21. Green JR, Müller K, Jaeggi KA: Preclinical pharmacology of CGP42′446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res 9:745-751, 1994.
22. Green JR: Chemical and biological prerequisites for novel bisphosphonate molecules: Results of comparative preclinical studies. Semin Oncol 28:4-10, 2001.
23. Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P: clodronate prevents prosthetic migration: A randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 71:553-557, 2000.
24. Horowitz SM, Algan SA, Purdon MA: Pharmacologic inhibition of particulate-induced bone resorption. J Biomed Mater Res 31:91-96, 1996.
25. Kienapfel H, Sumner DR, Turner TM, Urban RM, Galante JO: Efficacy of autograft and freeze-dried allograft to enhance fixation of porous coated implants in the presence of interface gaps. J Orthop Res 10:423-433, 1992.
26. Kuljanin J, Jankovic I, Nedeljkovic J, Prstojevic D, Marinkovic V: Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe (III) ions. J Pharm Biomed Anal 28:1215-1220, 2002.
27. Li EC, Davis LE: Zoledronic acid: A new parenteral bisphosphonate. Clin Ther 25:2669-2708, 2003.
28. Little DG, Cornell MS, Briody J, et al: Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis: A study in immature rabbits. J Bone Joint Surg 83B:1069-1074, 2001.
29. Little DG, Smith NC, Williams P, et al: Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res 18:1300-1307, 2003.
30. Longo JA, Weinstein AM, Hedley AK: the effects of collagen on tissue growth into a porous polyethylene ingrowth model. In Christel P, Meunier A, Lee AJC (eds). Biological and Biomechanical Performances of Biomaterials. New York, Elsevier 483-491, 1986.
31. McDonald DJ, Fitzgerald Jr RH, Chao EYS: The enhancement of fixation of a porous-coated femoral component by autograft and allograft in the dog. J Bone Joint Surg 70A:728-737, 1988.
32. McLaughlin RE, Reger SI, Bolander M, Eschenroeder HC: Enhancement of bone ingrowth by the use of bone matrix as a biologic cement. Clin Orthop Relat Res 183:255-261, 1984.
33. Ostovic D, Stelmach C, Hulshizer B: Formation of a chromophoric complex between alendronate and copper (II) ions. Pharm Res 10:470-472, 1993.
34. Overgaard S, Bromose U, Lind M, Bunger C, Soballe K: The influence of crystallinity of the hydroxyapatite coating on the fixation of implants: Mechanical and histomorphometric results. J Bone Joint Surg 81B:725-731, 1999.
35. Pataki A, Müller K, Green JR, et al: Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 249:458-468, 1997.
36. Peter B, Pioletti DP, Laib S, et al: Calcium phosphate drug delivery system: Influence of local zoledronate release on bone implant osseointegration. Bone 36:52-60, 2004.
37. Pidhorz LE, Urban RM, Jacobs JJ, Sumner DR, Galante JO: A quantitative study of bone and soft tissues in cementless porous-coated acetabular components retrieved at autopsy. J Arthroplasty 8:213-225, 1993.
38. Rivero DP, Fox J, Skipor AK, Urban RM, Galante JO: Calcium-phosphate- coated titanium implants for enhanced skeletal fixation. J Biomed Mater Res 22:191-201, 1988.
39. Russell RGG, Rogers MJ: Bisphosphonates: From the laboratory to the clinic and back again. Bone 25:97-106, 1999.
40. Russotti GM, Okada Y, Fitzgerald RH, Chao EYS, Gorski JP: Efficacy of using a bone graft substitute to enhance biological fixation of a porous metal femoral component. In Brand RA (ed). The Hip: Proceedings of 15th Open Scientific Meeting of the Hip Society. St. Louis, CV Mosby 120-154, 1987.
41. Ryd L, Albrektsson BE, Carlsson L, et al: Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg 77B:377-383, 1995.
42. Shanbhag AS, Hasselman CT, Rubash HE: Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 344:33-43, 1997.
43. Smith EJ, McEvoy A, Little DG, et al: Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis. J Bone Miner Res 19:1698-1705, 2004.
44. Soininvaara TA, Jurvelin JS, Miettinen HJA, et al: Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: A one-year, randomized, controlled trial of 19 patients. Calcif Tissue Int 71:472-477, 2002.
45. Sumner DR, Turner TM, Purchio AF, et al: Enhancement of bone ingrowth by transforming growth factor beta. J Bone Joint Surg 77A:1135-1147, 1995.
46. 2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J Orthop Res 19:85-94, 2001.
47. Sumner DR, Turner TM, Urban RM, et al: Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 22:58-65, 2004.
48. Sychterz CJ, Claus AM, Engh CA: What we have learned about long-term cementless fixation from autopsy retrievals. Clin Orthop Relat Res 405:79-91, 2002.
49. Tanzer M, Harvey E, Kay A, Morton P, Bobyn JD: Effect of non-invasive low intensity ultrasound on bone growth into porous-coated implants. J Orthop Res 14:901-906, 1996.
50. Tanzer M, Kantor S, Bobyn JD: Enhancement of bone growth into porous intramedullary implants using non-invasive low intensity ultrasound. J Arthroplasty 19:195-199, 2002.
51. Teloken MA, Bissett G, Hozack WJ, Sharkey PF, Rothman RH: Ten to fifteen-year follow-up after total hip arthroplasty with a tapered cobalt-chromium femoral component (tri-lock) inserted without cement. J Bone Joint Surg 84A:2140-2144, 2002.
52. Venesmaa PK, Kroger HP, Miettinen HJ, et al: Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: A prospective randomized study. J Bone Miner Res 16:2126-2131, 2001.
53. Wilkinson JM, Stockley I, Peel NF, et al: Effect of pamidronate in preventing local bone loss after total hip arthroplasty: A randomized, double-blind, controlled trial. J Bone Miner Res 16:556-564, 2001.
54. Yaffe A, Iztkovich M, Earon Y, et al: Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 68:884-889, 1997.